Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

NCT01654354 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2014-01-14

No results posted yet for this study

Summary

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT

Conditions

  • Abdominal CT

Interventions

DRUG

NEOVIST 370 INJ.(Iopromide 768.86mg)

DRUG

Ultravist 370 INJ.(Iopromide 768.86mg)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-11-30
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654354 on ClinicalTrials.gov